Adverse-event reports (MAUDE)
Read this first: MAUDE report counts cannot be used to compute incidence rates or compare device safety. Reporting is incomplete, duplicated, and spikes with publicity; there is no denominator of devices in use. The peer line shows reporting volume for the average device in the same FDA product code — a reporting baseline, not a risk measure.
6 linked reportsInjury 4Malfunction 2
| Month | This device (reports) | Product-code average (reports per device) |
|---|---|---|
| 2019-01 | 0 | 2.64 |
| 2019-02 | 0 | 3.27 |
| 2019-03 | 0 | 2.21 |
| 2019-04 | 0 | 2.4 |
| 2019-05 | 0 | 2.18 |
| 2019-06 | 0 | 3.28 |
| 2019-07 | 0 | 3.95 |
| 2019-08 | 0 | 3.9 |
| 2019-09 | 0 | 2.53 |
| 2019-10 | 0 | 3.61 |
| 2019-11 | 0 | 3.11 |
| 2019-12 | 0 | 3.55 |
| 2020-01 | 0 | 3.91 |
| 2020-02 | 0 | 5.88 |
| 2020-03 | 0 | 3.63 |
| 2020-04 | 0 | 3.42 |
| 2020-05 | 0 | 4.13 |
| 2020-06 | 0 | 3.5 |
| 2020-07 | 0 | 3.28 |
| 2020-08 | 0 | 3.71 |
| 2020-09 | 0 | 3.21 |
| 2020-10 | 0 | 3.89 |
| 2020-11 | 0 | 4.39 |
| 2020-12 | 0 | 4.48 |
| 2021-01 | 0 | 3.62 |
| 2021-02 | 0 | 3.65 |
| 2021-03 | 0 | 3 |
| 2021-04 | 0 | 3.29 |
| 2021-05 | 0 | 3.35 |
| 2021-06 | 0 | 2.53 |
| 2021-07 | 0 | 2.68 |
| 2021-08 | 0 | 3.19 |
| 2021-09 | 0 | 4 |
| 2021-10 | 0 | 4 |
| 2021-11 | 0 | 4.62 |
| 2021-12 | 0 | 4.36 |
| 2022-01 | 0 | 4.08 |
| 2022-02 | 0 | 5.7 |
| 2022-03 | 0 | 4.5 |
| 2022-04 | 0 | 2.69 |
| 2022-05 | 0 | 2.38 |
| 2022-06 | 0 | 3.81 |
| 2022-07 | 0 | 3.17 |
| 2022-08 | 0 | 1.84 |
| 2022-09 | 0 | 2.82 |
| 2022-10 | 0 | 3.67 |
| 2022-11 | 0 | 1.77 |
| 2022-12 | 0 | 3.07 |
| 2023-01 | 0 | 2.73 |
| 2023-02 | 0 | 2.82 |
| 2023-03 | 0 | 2.85 |
| 2023-04 | 0 | 2.62 |
| 2023-05 | 0 | 2.88 |
| 2023-06 | 0 | 3.52 |
| 2023-07 | 0 | 2.31 |
| 2023-08 | 0 | 3.3 |
| 2023-09 | 0 | 2.5 |
| 2023-10 | 0 | 3.17 |
| 2023-11 | 0 | 3.07 |
| 2023-12 | 0 | 2.79 |
| 2024-01 | 0 | 2.65 |
| 2024-02 | 0 | 3.08 |
| 2024-03 | 0 | 2.45 |
| 2024-04 | 0 | 3.24 |
| 2024-05 | 0 | 2.7 |
| 2024-06 | 2 | 1.73 |
| 2024-07 | 0 | 2.53 |
| 2024-08 | 0 | 3.2 |
| 2024-09 | 0 | 2.36 |
| 2024-10 | 0 | 2.81 |
| 2024-11 | 0 | 2.44 |
| 2024-12 | 0 | 2.55 |
| 2025-01 | 4 | 1.89 |
| 2025-02 | 0 | 2.82 |
| 2025-03 | 0 | 1.65 |
| 2025-04 | 0 | 3.24 |
| 2025-05 | 0 | 2 |
| 2025-06 | 0 | 2.68 |
| 2025-07 | 0 | 2.21 |
| 2025-08 | 0 | 1.5 |
| 2025-09 | 0 | 1.88 |
| 2025-10 | 0 | 2.43 |
| 2025-11 | 0 | 1.6 |
| 2025-12 | 0 | 2.35 |
| 2026-01 | 0 | 1.94 |
| 2026-02 | 0 | 2 |
| 2026-03 | 0 | 1.76 |
| 2026-04 | 0 | 4.18 |
| 2026-05 | 0 | 3.5 |
| 2026-06 | 0 | 2.58 |
Failure-mode summaryAI-generated
6 linked report narratives available — no AI summary generated yet.
Recall history
| Initiated | Recall # | Class | Status | Reason | Quantity | Link basis |
|---|---|---|---|---|---|---|
| 2025-02-26 | Z-1512-2025 | Class I | Open, Classified | Aspiration catheter distal tip features and characteristics may not be in the scope of FDA clearance; tip detachment, vessel rupture, and vasospasm could occur.Distribution: US: CA, IL, NE, TN, TX, NJ, NC, SD, FL, MI, PA, GA, AL, IN, NY, WI, AZ, MN, LA, OH, OK, SC, NV, ND, ID, MO, CT, WA, MA. OUS: QATAR, United Arab Emirates, Republic of Kazakhstan | 1617 | code info di |
Individual MAUDE reports
| Date | Report # | Type | Narrative | Link basis |
|---|---|---|---|---|
| 2025-01-31 | 3015614180-2025-00001 | Injury | Available | catalog number |
| 2025-01-31 | 3015614180-2025-00002 | Injury | Available | catalog number |
| 2024-06-21 | 3015614180-2024-00007 | Malfunction | Available | catalog number |
Showing the most recent 3 of 6 linked reports.
Regulatory clearances
- 510(k)K222786Substantially equivalent (SESE) · 2023-08-25clearance family
Manufacturer compliance record
| Date | Type | Outcome | Facility | Citations |
|---|---|---|---|---|
| 2025-02-05 | WL | Warning Letter | Q'apel Medical, Inc. | — |
| 2024-08-08 | OAI | Official action indicated | Qapel Medical Inc. | 7 |
| 2022-03-08 | VAI | Voluntary action indicated | Q'apel Medical, Inc. | 2 |